Company / SG&A Expense
STAAR Surgical Company SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$274.1M
FY2025
5-year range
$100.1M / $274.1M
FY2021-FY2025
Trend
+8.7%
vs FY2024
Sector context
#91 of 158
Health Care
What the data says
At $274M, STAAR Surgical Company's sg&a expense ranks #68 of 158 in the Health Care sector. SG&A Expense has increased for 5 consecutive years, from $85M in FY2020 to $274M in FY2025.
Based on SEC 10-K filings.
$274M in FY2025 with a 5-year CAGR of +26.4%.
Increased from $225M to $274M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- +26.4%
- 10-Year CAGR
- -
Sector benchmark
#68 of 158 in Health CareTop 42% of 158This company $274.1M Sector average $175.9B
▼
-99.8% below sector average
Key checks
Key Insights
- STAAR Surgical Company's sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +26.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 8.7% year-over-year.
- Ranks #91 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $274.1M | +8.7% |
| FY2024 | $252.2M | +12.3% |
| FY2023 | $224.6M | +25.0% |
| FY2022 | $179.6M | +79.4% |
| FY2021 | $100.1M | +17.9% |
| FY2020 | $84.9M | -15.2% |
| FY2019 | $100.1M | +40.9% |
| FY2018 | $71.0M | +262.3% |
| FY2017 | $19.6M | -72.4% |
| FY2016 | $71.0M | +262.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026